On Thursday the 19th of January 2023; Neuro-Bio’s CEO, Susan Greenfield, talked at the Next Generation Forum 2023. The event was an exciting line-up of promising young talent, interesting product launches and unusual asset classes. Susan Greenfield explained her vision of investing in the 21st century brain by exploring a disruptive approach based on the pivotal mechanism of neurodegeneration. This is what Neuro-Bio is focusing on: the combination of a presymptomatic screen coupled with an drug treatment that halted cell loss, would amount to an effective ‘cure’.

Click the link for more information about the event.